Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The […]